Expert Biomarker Testing Support
ACM’s bioanalytical scientists work seamlessly with you, from developing assays to reporting data. Our pharmacodynamic (PD) biomarker studies enhance traditional drug development methods. Using advanced methodologies to study biomarkers in the evaluation of a drug’s performance in patients receiving treatment who are in clinical trials. This complements our drug analysis services since both PK and PD testing can be performed in the same laboratory, requiring one plasma sample per patient. Our expanding reach opens up greater opportunities in the biomarker arena to connect CLIA and GLP settings.
Get Started Now